Gaithersburg’s Emergent BioSolutions Inc. just added another task to its ever-growing to-do list: Develop a device to stop seizures caused by chemical weapons. The company, which has two manufacturing sites in Baltimore, has secured about $20 million from the Department of Defense to design an auto-injector — a shot that can be given easily without medical training — to administer seizure drug diazepam, Emergent (NYSE: EBS) announced Thursday. The product would reverse the effects of nerve…
from https://www.bizjournals.com/baltimore/news/2019/09/27/emergent-lands-20m-contract-to-develop-chemical.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/187979674052
No comments:
Post a Comment